Description
Glivec
- Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in children and adults;
- Ph+ CML in the chronic phase with failure of previous therapy with interferon alfa or in the phase of acceleration or blast crisis in children and adults;
- Newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adult patients in combination with chemotherapy;
- Relapsed or refractory Ph+ ALL in adult patients as monotherapy;
- Myelodysplastic / myeloproliferative diseases associated with gene rearrangements of the platelet growth factor receptor in adult patients;
- Systemic mastocytosis in adult patients with no D816V c-Kit mutation or with unknown c-Kit mutational status;
- Hypereosinophilic syndrome and/or chronic eosinophilic leukemia in adults with positive or negative abnormal FIP1L1-PDGRF alpha tyrosine kinase;
- Unresectable and/or metastatic malignant gastrointestinal stromal tumors positive for c-Kit (CD 117) in adult patients;
- Adjuvant therapy of gastrointestinal stromal tumors positive for c-Kit (CD 117) in adult patients;inoperable, recurrent and/or metastatic dermatofibrosarcoma bulging in adult patients.
Active ingredient: imatinib
Prescription medicine.
